LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 271

Search options

  1. Article ; Online: Time to First Whole Blood Associated With Survival-First (Whole) Blood?

    Sperry, Jason L / Neal, Matthew D

    JAMA surgery

    2024  Volume 159, Issue 4, Page(s) 381–382

    Language English
    Publishing date 2024-01-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701841-6
    ISSN 2168-6262 ; 2168-6254
    ISSN (online) 2168-6262
    ISSN 2168-6254
    DOI 10.1001/jamasurg.2023.7186
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Whole-Blood Resuscitation Following Traumatic Injury and Hemorrhagic Shock-Should It Be Standard Care?

    Sperry, Jason L / Brown, Joshua B

    JAMA surgery

    2023  Volume 158, Issue 5, Page(s) 540

    MeSH term(s) Animals ; Humans ; Shock, Hemorrhagic/etiology ; Shock, Hemorrhagic/therapy ; Resuscitation ; Disease Models, Animal
    Language English
    Publishing date 2023-01-18
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2701841-6
    ISSN 2168-6262 ; 2168-6254
    ISSN (online) 2168-6262
    ISSN 2168-6254
    DOI 10.1001/jamasurg.2022.6986
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Invited Commentary: Why Would We Withhold a Beneficial Treatment? Use of Low-Titer Group O-Positive Whole Blood in Women of Childbearing Age.

    Sperry, Jason L / Yazer, Mark H

    Journal of the American College of Surgeons

    2023  Volume 238, Issue 3, Page(s) 357–358

    MeSH term(s) Female ; Humans ; ABO Blood-Group System ; Withholding Treatment
    Chemical Substances ABO Blood-Group System
    Language English
    Publishing date 2023-11-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1181115-8
    ISSN 1879-1190 ; 1072-7515
    ISSN (online) 1879-1190
    ISSN 1072-7515
    DOI 10.1097/XCS.0000000000000909
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prehosptial low titer group O whole blood is feasible and safe: Results of a prospective randomized pilot trial.

    Guyette, Frank X / Sperry, Jason L

    The journal of trauma and acute care surgery

    2022  Volume 93, Issue 5, Page(s) e175–e176

    MeSH term(s) Humans ; Prospective Studies ; Pilot Projects ; ABO Blood-Group System ; Transfusion Reaction
    Chemical Substances ABO Blood-Group System
    Language English
    Publishing date 2022-06-14
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Comment
    ZDB-ID 2651070-4
    ISSN 2163-0763 ; 2163-0755
    ISSN (online) 2163-0763
    ISSN 2163-0755
    DOI 10.1097/TA.0000000000003686
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Prehospital Tranexamic Acid Administration in Injured Patients-Reply.

    Guyette, Francis X / Brown, Joshua B / Sperry, Jason L

    JAMA surgery

    2021  Volume 156, Issue 7, Page(s) 688–689

    MeSH term(s) Antifibrinolytic Agents ; Emergency Medical Services ; Humans ; Injury Severity Score ; Tranexamic Acid
    Chemical Substances Antifibrinolytic Agents ; Tranexamic Acid (6T84R30KC1)
    Language English
    Publishing date 2021-03-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2701841-6
    ISSN 2168-6262 ; 2168-6254
    ISSN (online) 2168-6262
    ISSN 2168-6254
    DOI 10.1001/jamasurg.2021.0262
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Prehospital Plasma Transfusion: What Does the Literature Show?

    Jackson, Bryon P / Sperry, Jason L / Yazer, Mark H

    Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

    2021  Volume 48, Issue 6, Page(s) 358–365

    Abstract: Background: Early initiation of blood products transfusion after injury has been associated with improved patient outcomes following traumatic injury. The ability to transfuse patients' plasma in the prehospital setting provides a prime opportunity to ... ...

    Abstract Background: Early initiation of blood products transfusion after injury has been associated with improved patient outcomes following traumatic injury. The ability to transfuse patients' plasma in the prehospital setting provides a prime opportunity to begin resuscitation with blood products earlier and with a more balanced plasma: RBC ratio than what has traditionally been done. Published studies on the use of prehospital plasma show a complex relationship between its use and improved survival.
    Summary: Examination of the literature shows that there may be a mortality benefit from the use of prehospital plasma, but that it may be limited to certain subgroups of trauma patients. The likelihood of realizing these survival benefits appears to be predicted by several factors including the type of injury, length of transport time, presence of traumatic brain injury, and total number of blood products transfused, whether the patient required only a few products or a massive transfusion. When taken as a whole the evidence appears to show that prehospital plasma may have a mortality benefit that is most clearly demonstrated in patients with blunt injuries, moderate transfusion requirements, traumatic brain injury, and/or transport time greater than 20 min, as well as those who demonstrate a certain cytokine expression profile.
    Key messages: The evidence suggests that a targeted use of prehospital plasma will most likely maximize the benefits from the use of this limited resource. It is also possible that prehospital plasma may best be provided through whole blood as survival benefits were greatest in patients who received both prehospital plasma and RBCs.
    Language English
    Publishing date 2021-10-14
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2100848-6
    ISSN 1660-3818 ; 1660-3796
    ISSN (online) 1660-3818
    ISSN 1660-3796
    DOI 10.1159/000519627
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: How do we forecast tomorrow's transfusion? Prehospital transfusion.

    Yazer, Mark H / Jenkins, Donald H / Sperry, Jason L / Spinella, Philip C

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

    2022  Volume 30, Issue 1, Page(s) 39–42

    MeSH term(s) Humans ; Blood Transfusion ; Emergency Medical Services ; Wounds and Injuries
    Language English
    Publishing date 2022-07-30
    Publishing country France
    Document type Journal Article
    ZDB-ID 1204698-x
    ISSN 1953-8022 ; 1246-7820
    ISSN (online) 1953-8022
    ISSN 1246-7820
    DOI 10.1016/j.tracli.2022.07.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.

    Yazer, Mark H / Spinella, Philip C / Sperry, Jason / Triulzi, Darrell J / Leeper, Christine

    Transfusion

    2023  Volume 63 Suppl 3, Page(s) S54–S59

    Abstract: Background: The D-alloimmunization rate in trauma patients does not appear to depend on the number of RhD-positive units transfused. The effect of the timing and pattern of RhD-positive transfusions has not been evaluated.: Methods: RhD-negative ... ...

    Abstract Background: The D-alloimmunization rate in trauma patients does not appear to depend on the number of RhD-positive units transfused. The effect of the timing and pattern of RhD-positive transfusions has not been evaluated.
    Methods: RhD-negative trauma patients who were transfused with RhD-positive red blood cells (RBC) or low titer group O whole blood (collectively called RBCs) on at least two separate calendar days and who had antibody detection tests performed at least 14 days after the second RhD-positive RBC transfusion without receiving RhIg were included in the analysis. Patients whose anti-D was detected within 14 days of the index RhD-positive RBC transfusion were excluded. Patient demographics and the dates of RhD-positive RBC transfusions and results of antibody detection tests performed after the index transfusion were collected on eligible patients.
    Results: There were 44/61 (72.1%) patients in whom anti-D was not detected (non-alloimmunized) and 17/61 (27.9%) in whom anti-D was detected (alloimmunized). The patients had similar demographics with trends towards higher median admission heart rates and lower median admission Glasgow Coma Scale values in the alloimmunized group. Both groups received statistically identical median quantities of RhD-positive RBCs (non-alloimmunized 5 vs. alloimmunized 4 units, p = .53), however, the alloimmunized group received all their RhD-positive RBCs over a significantly shorter period of time compared to the non-alloimmunized (median 4 vs. 15 days, respectively, p = .01).
    Conclusion: Receipt of all RhD-positive RBCs over a shorter period of time was associated with higher D-alloimmunization rates. These results need to be confirmed in larger studies.
    MeSH term(s) Humans ; Isoantibodies ; Erythrocytes ; Erythrocyte Transfusion/methods ; Blood Transfusion/methods ; Anemia, Hemolytic, Autoimmune
    Chemical Substances Isoantibodies
    Language English
    Publishing date 2023-04-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.17330
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.

    Yazer, Mark H / Triulzi, Darrell J / Sperry, Jason L / Seheult, Jansen N

    Transfusion

    2021  Volume 61 Suppl 1, Page(s) S150–S158

    Abstract: Introduction: Early transfusion reduces mortality in bleeding patients. In this setting, RhD-positive blood products might be transfused. This study determined the association between the RhD-alloimmunization rate and the number of RhD-positive products ...

    Abstract Introduction: Early transfusion reduces mortality in bleeding patients. In this setting, RhD-positive blood products might be transfused. This study determined the association between the RhD-alloimmunization rate and the number of RhD-positive products transfused.
    Methods: RhD-negative patients between 13 and 50 years who were transfused with ≥1 RhD-positive red blood cell (RBC) or whole blood units between January 1, 2000 and December 31, 2019 in a healthcare network were identified. Study patients had to have had at least one antibody detection test performed ≥14 days after the index RhD-positive transfusion and not receive RhIg. Patients were stratified into groups that received 1, 2, 3-5, 6-10, 11-20, and >20 RhD-positive transfusions and the RhD-alloimmunization rate was determined for each group.
    Results: There were 335 patients included; 52/335 (15.5%) were females. Overall, there were 117/335 (34.9%, CI: 29.8%-40.3%) recipients who became RhD-alloimmunized. There was no significant dosage effect in the RhD-alloimmunization rates as the exposure to RhD-positive units increased from one RhD-positive unit to more than 20 RhD-positive units (p = .270 for non-parametric trend test). In an exploratory analysis, patients who received 100% of their RhD-positive transfusions within 72 h of the index transfusion had a significantly higher rate of RhD-alloimmunization compared to those who were transfused over a longer period of time (42.3% vs. 21.4%, respectively; p = .001).
    Conclusion: These results suggest that there may not be an increased RhD-alloimmunization risk with transfusing multiple RhD-positive units after one RhD-positive unit has been transfused. These findings need confirmation in larger studies.
    MeSH term(s) Adult ; Erythrocyte Transfusion/adverse effects ; Erythrocytes/immunology ; Female ; Humans ; Isoantibodies/blood ; Isoantibodies/immunology ; Male ; Middle Aged ; Rh-Hr Blood-Group System/blood ; Rh-Hr Blood-Group System/immunology ; Young Adult
    Chemical Substances Isoantibodies ; Rh-Hr Blood-Group System
    Language English
    Publishing date 2021-07-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208417-x
    ISSN 1537-2995 ; 0041-1132
    ISSN (online) 1537-2995
    ISSN 0041-1132
    DOI 10.1111/trf.16495
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.

    Yazer, Mark / Triulzi, Darrell / Sperry, Jason / Corcos, Alain / Seheult, Jansen

    Hematology (Amsterdam, Netherlands)

    2021  Volume 26, Issue 1, Page(s) 321–327

    Abstract: Objectives: To determine the rate of RhD-alloimmunization in injured RhD-negative patients in the age range of childbearing potential who were transfused with at least one unit of RhD-positive red blood cells (RBC) or low titer group O whole blood ( ... ...

    Abstract Objectives: To determine the rate of RhD-alloimmunization in injured RhD-negative patients in the age range of childbearing potential who were transfused with at least one unit of RhD-positive red blood cells (RBC) or low titer group O whole blood (LTOWB).
    Methods: Injured RhD-negative patients between the ages of 13-50 at an American Level 1 trauma center who were transfused with at least one unit of RBCs or LTOWB during their resuscitation and who had an antibody detection test performed at least 14 days afterwards were included.
    Results: Over a 20-year period, 96 study-eligible patients were identified, of which 90/96 (93.8%) were male. The median age of these 96 patients was 33 (5th-95th percentiles: 19-49) years. The majority of these patients (71/96, 74.0%) had an injury severity score (ISS) greater than 15. Overall, 41/96 (42.7%; 95% CI: 32.7%-53.2%) of these patients became alloimmunized after receipt of a median of 3 (5th-95th percentiles: 1-35) units of RhD-positive RBCs and/or LTOWB. There was no association between receipt of leukoreduced RBCs or receipt of LTOWB and the RhD-alloimmunization rate.
    Discussion: The rate of RhD-alloimmunization in this study was at the higher end of rates that have been reported. None of the previous studies focused exclusively on trauma patients in the childbearing age range.
    Conclusion: The 42.7% rate of RhD-alloimmunization in a predominantly male trauma population could probably be extrapolated to women in the same age range when estimating their risk of RhD-alloimmunization following RhD-positive transfusion.
    MeSH term(s) Adolescent ; Adult ; Blood Transfusion ; Erythrocyte Transfusion ; Female ; Humans ; Isoantibodies/immunology ; Male ; Middle Aged ; Resuscitation ; Rh-Hr Blood-Group System/immunology ; Transfusion Reaction/immunology ; Wounds and Injuries/immunology ; Wounds and Injuries/therapy ; Young Adult
    Chemical Substances Isoantibodies ; Rh-Hr Blood-Group System ; Rho(D) antigen
    Language English
    Publishing date 2021-04-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 1341428-8
    ISSN 1607-8454 ; 1024-5332 ; 1024-5340
    ISSN (online) 1607-8454
    ISSN 1024-5332 ; 1024-5340
    DOI 10.1080/16078454.2021.1905395
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top